Evaluating outcomes of hepatobiliopancreatic surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the post-surgical morbidity and mortality outcomes of patients who have undergone surgery by the Hepatobiliopancreatic (HPB) Surgical Unit. It will utilize established international classifications to evaluate these outcomes, as well as survival and disease-free survival rates for patients operated on due to tumoral causes. The study includes both retrospective data from the last 10 years and prospective data from patients who consent to participate from January 2019 onwards.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)
* All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).

Exclusion Criteria:

* Patients not eligible for surgery
* Patients not interested in taking part in the study

Where it's running

• Complejo Hospitalario de Navarra
  Pamplona, Navarre, Spain Recruiting

Study contacts

• Principal investigator: Francisco Javier Herrera Cabezón, MD — Complejo Hospitalario de Navarra
• Study coordinator: Francisco Javier Herrera Cabezón, MD
• Email: javier.herrera.cabezon@cfnavarra.es
• Phone: 0034 848422187

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How quickly blood albumin returns after major liver, pancreas, or bile-duct surgery predicts recovery

  This study will see if the speed at which serum albumin returns after major hepato‑pancreato‑biliary surgery predicts complications and hospital stay for patients aged 12 and up.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07263061

• Everolimus-based calcineurin-free immunosuppression one year after liver transplant

  This trial tests whether switching to or using everolimus with reduced calcineurin inhibitors after year one post-liver transplant can protect kidney function while maintaining graft health in adults at low rejection risk.

  Recruiting Phase 3 Hannover Medical School · Heidelberg, Baden-Wurttemberg and 15 other locations · NCT07739914

• Metastatic liver cancer patient registry from multiple Chinese centers

  This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.

  Recruiting at 2 sites Anhui Provincial Hospital · Bengbu, Anhui and 2 other locations · NCT07602504

• Rectal indomethacin plus cold-water ampullary cooling to lower pancreatitis after ERCP

  This will test whether adding cold-water cooling of the ampulla to standard rectal indomethacin lowers the chance of pancreatitis in adults having ERCP.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT07574970

• How dexamethasone affects blood sugar during and after non-cardiac surgery

  We will see if a standard dose of dexamethasone raises blood sugar in adults having elective non-cardiac surgery and whether continuous glucose monitors detect changes better than finger-prick tests.

  Recruiting Zealand University Hospital · Roskilde · NCT07573930

• Safety and how the drug behaves in adults with moderate to severe liver impairment

  This study tests the safety and how INCB123667 moves through the body when taken by adults with moderate to severe liver impairment.

  Recruiting at 4 sites Phase 1 Incyte Corporation · Chandler, Arizona and 3 other locations · NCT07559474

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.